Olin Corporation operates as a major player in chemicals and ammunition through its Chlor Alkali Products and Vinyls, Epoxy, and Winchester segments. This quarter stands out because the company continues to navigate weak commodity chemical pricing, subsidized Asian exports, and higher feedstock costs that have compressed margins. The results also arrive as Olin moves forward with its proposed merger with Huntsman, which adds layers of integration and financing considerations for investors. With the stock trading well below its 52-week high and down sharply over the past year, the report offered a useful checkpoint on whether the value-first strategy can support earnings stability.
For the third quarter ended September 30, 2026, Olin posted sales of $1.75 billion, a modest increase from $1.71 billion a year earlier. Net income attributable to Olin Corporation reached $14.4 million, or $0.13 per diluted share, compared with $42.8 million in the same period last year. On a GAAP basis, these figures landed below analyst expectations of roughly $0.15–$0.16 per share, and revenue of $1.75 billion fell short of consensus estimates near $1.83–$1.84 billion.
Adjusted EBITDA came in at $191.4 million, which management viewed as aligned with its internal planning. Segment performance showed contrasts: Chlor Alkali Products and Vinyls sales dropped to $850.8 million from $924.0 million, while Epoxy sales climbed to $412.2 million from $349.6 million and Winchester sales rose to $484.7 million from $439.6 million. Acquisition-related costs tied to the Huntsman deal totaled $13.7 million in the quarter.
Looking ahead, Olin expects fourth quarter 2026 adjusted EBITDA in the $80 million to $100 million range, reflecting typical seasonality, year-end destocking by customers, higher feedstock costs, and planned maintenance turnarounds. The company also updated its timeline for the Huntsman transaction, now anticipating a close in the first quarter of 2027 subject to standard conditions.
Heading into the release, expectations had softened and the stock had already declined roughly 20% since the start of the year while broader markets moved higher. The miss on both revenue and earnings lines highlighted ongoing challenges in chemical pricing and margins, even though adjusted EBITDA met management’s own targets. Shares have moved from a 52-week high near $30 down to the mid-teens, underscoring the pressure the business has faced. Investors continue to weigh the potential longer-term benefits of the Huntsman combination against near-term costs and uncertainties.
The immediate focus is the fourth-quarter guidance, which signals a step down in adjusted EBITDA. Management pointed to seasonality, customer destocking, feedstock cost increases, Asian export pressures, and maintenance schedules as key drivers. I’m watching closely to see whether chemical prices stabilize and if volumes can help offset any further pricing weakness.
The Huntsman merger remains another important element, with the updated close window in the first quarter of 2027. Progress on regulatory approvals, integration planning, and financing will likely influence sentiment. In addition, the Beyond250 cost-savings program and the value-first approach stay central to margin improvement. Olin ended the quarter with net debt near $2.8 billion and a net debt to adjusted EBITDA ratio of about 5.2 times, so cash generation and cost control will stay relevant.
I also checked this using Tickeron’s AI Screener to compare Olin against other names in the sector and review technical setups. These tools help surface patterns and fundamentals efficiently when reviewing earnings reports like this one.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where OLN advanced for three days, in 181 of 274 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where OLN's RSI Oscillator exited the oversold zone, 25 of 38 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 66%.
The Momentum Indicator moved above the 0 level on October 23, 2026. You may want to consider a long position or call options on OLN as a result. In 49 of 75 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 65%.
The Moving Average Convergence Divergence (MACD) for OLN just turned positive on October 15, 2026. Looking at past instances where OLN's MACD turned positive, the stock continued to rise in 26 of 48 cases over the following month. The odds of a continued upward trend are 54%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
OLN moved below its 50-day moving average on October 28, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where OLN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.
OLN broke above its upper Bollinger Band on October 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for OLN entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 44 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.069) is normal, around the industry mean (1.167). P/E Ratio (-9.277) is within average values for comparable stocks, (3.030). Projected Growth (PEG Ratio) (1.050) is also within normal values, averaging (3.769). Dividend Yield (0.050) settles around the average of (0.180) among similar stocks. P/S Ratio (0.289) is also within normal values, averaging (0.578).
The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating fairly steady price growth. OLN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OLN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a company which engages in manufacturing and distributing the chemicals products
Industry ChemicalsMajorDiversified